Successful treatment of anal and perianal condyloma acuminata with imiquimod. 2014

Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
Department of Dermatology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003218 Condylomata Acuminata Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses. Genital Warts,Venereal Warts,Warts, Genital,Warts, Venereal,Genital Wart,Venereal Wart,Wart, Genital,Wart, Venereal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077271 Imiquimod A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS. 1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine,Aldara,R 837,R-837,S 26308,S-26308,Zyclara,R837
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000634 Aminoquinolines Quinolines substituted in any position by one or more amino groups.
D001004 Anus Diseases Diseases involving the ANUS. Anus Disease,Disease, Anus,Diseases, Anus
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
February 1980, American journal of proctology,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
January 2009, Dermatology online journal,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
October 1965, Prensa medica argentina,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
January 2001, Acta dermato-venereologica,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
June 1978, Journal of the Royal Society of Medicine,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
July 1983, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
December 1994, Nihon rinsho. Japanese journal of clinical medicine,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
January 1994, Ryoikibetsu shokogun shirizu,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
April 1979, The Journal of dermatologic surgery and oncology,
Chisato Tawada, and Yoko Oshitani, and Masaki Kimura, and Mariko Seishima
June 1971, The Journal of urology,
Copied contents to your clipboard!